Content validity of overtreatment and undertreatment in older adults with cancer: A multi-stakeholder qualitative study of new definitions.
Abstract
382 Background: Over- and undertreatment (OT/UT) are widely cited in the care of older adults with cancer, yet the terms lack standardized definitions. We previously proposed new definitions that incorporate geriatric assessment and patient preferences alongside cancer-specific factors, and grounded these definitions in core ethical principles (DuMontier et al., BMC Med Ethics, 2025). To ensure that the definitions are comprehensive in reflecting the relevant facets of the patient lived experience and clinical realities, we sought to assess their content validity through interviews with older adults, caregivers, and oncologists. Methods: We conducted semi-structured virtual interviews (May 2025–January 2026) with older adults with cancer (≥70 years), caregivers, and oncologists. Participants were purposively sampled through patient and professional networks to capture diverse perspectives (e.g., oncology subspecialty and cancer type). The research team, including patient advocates (CARG SCOREboard), developed interview guides with a focus on clarity, relevance, value, comprehensiveness, and acceptability. Interviews were conducted by an experienced qualitative researcher and analyzed by framework analysis, with triangulating across group perspectives. Recruitment continued until meaning saturation was achieved (Hennik et al., Qual. Health Res., 2017). Results: Participants (n=18) confirmed the relevance, value, and comprehensiveness of the proposed definitions of OT/UT. Participants endorsed them as improving upon current approaches for older adults with cancer by providing clearer criteria that emphasized treatment decision-making grounded in a holistic understanding of the patient. All groups supported incorporating patient values and formal frailty assessment into treatment decisions, consistent with prior evidence that such assessment informs benefit-harm evaluation; however, participants raised feasibility concerns in clinic and the risks of over-reliance on frailty scores without contextualization. Among oncologists, the definitions offered a beneficial structure to support treatment recommendations that may vary from guideline-recommended regimens, especially amid pressures to prioritize aggressive cancer control when misaligned with frailty or patient preferences. Participants provided minor critiques on grammar and clarity. Conclusions: These findings confirm and enhance the content validity of OT/UT definitions through incorporation of stakeholder perspectives. Participants viewed the definitions as more structured and clinically useful than current practice, offering an ethical reference to support treatment recommendations that differ from guideline- or standard-intensity approaches when clinically and ethically appropriate for the individual patient.